New drug hopes to help failing hearts after bypass
Disease control
Not yet recruiting
This study tests a new medicine called ADR-002K in 50 people with heart failure caused by blocked heart arteries who are having bypass surgery. The goal is to see if the drug can improve heart function and reduce heart problems over two years. Participants will have regular heart…
Phase: PHASE2 • Sponsor: Rohto Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC